ID   NFIA_HUMAN              Reviewed;         509 AA.
AC   Q12857; B4DRJ3; B4DS53; F5H0R0; F8W8W3; Q8TA97; Q9H3X9; Q9P2A9;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   18-JUN-2025, entry version 211.
DE   RecName: Full=Nuclear factor 1 A-type;
DE            Short=NF1-A;
DE            Short=Nuclear factor 1/A;
DE   AltName: Full=CCAAT-box-binding transcription factor;
DE            Short=CTF;
DE   AltName: Full=Nuclear factor I/A;
DE            Short=NF-I/A;
DE            Short=NFI-A;
DE   AltName: Full=TGGCA-binding protein;
GN   Name=NFIA; Synonyms=KIAA1439;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-243.
RX   PubMed=7590749; DOI=10.1006/geno.1995.1107;
RA   Qian F., Kruse U., Lichter P., Sippel A.E.;
RT   "Chromosomal localization of the four genes (NFIA, B, C, and X) for the
RT   human transcription factor nuclear factor I by FISH.";
RL   Genomics 28:66-73(1995).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-265; SER-280;
RP   SER-287; SER-300 AND SER-319, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280 AND SER-287, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265; SER-280; SER-287;
RP   SER-300 AND SER-360, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280; SER-287 AND SER-300, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   INVOLVEMENT IN BRMUTD.
RX   PubMed=24462883; DOI=10.1016/j.ejmg.2013.12.011;
RA   Rao A., O'Donnell S., Bain N., Meldrum C., Shorter D., Goel H.;
RT   "An intragenic deletion of the NFIA gene in a patient with a hypoplastic
RT   corpus callosum, craniofacial abnormalities and urinary tract defects.";
RL   Eur. J. Med. Genet. 57:65-70(2014).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265; SER-280; SER-287;
RP   SER-300; SER-469 AND THR-471, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-469 (ISOFORM 2), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   INVOLVEMENT IN BRMUTD.
RX   PubMed=27081522; DOI=10.1038/hgv.2015.7;
RA   Negishi Y., Miya F., Hattori A., Mizuno K., Hori I., Ando N., Okamoto N.,
RA   Kato M., Tsunoda T., Yamasaki M., Kanemura Y., Kosaki K., Saitoh S.;
RT   "Truncating mutation in NFIA causes brain malformation and urinary tract
RT   defects.";
RL   Hum. Genome Var. 2:15007-15007(2015).
RN   [15]
RP   9AATAD MOTIF.
RX   PubMed=31375868; DOI=10.1007/s00018-019-03251-w;
RA   Piskacek M., Havelka M., Jendruchova K., Knight A., Keegan L.P.;
RT   "The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with
RT   valines and intron reservoirs.";
RL   Cell. Mol. Life Sci. 77:1793-1810(2020).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the
CC       origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC   -!- INTERACTION:
CC       Q12857-2; Q9H0R8: GABARAPL1; NbExp=3; IntAct=EBI-12119652, EBI-746969;
CC       Q12857-2; A0A0S2Z4H3: NFIB; NbExp=3; IntAct=EBI-12119652, EBI-16430952;
CC       Q12857-2; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-12119652, EBI-742388;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q12857-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12857-2; Sequence=VSP_036620;
CC       Name=3;
CC         IsoId=Q12857-3; Sequence=VSP_046884;
CC       Name=4;
CC         IsoId=Q12857-4; Sequence=VSP_046883;
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:31375868}.
CC   -!- DISEASE: Brain malformations with or without urinary tract defects
CC       (BRMUTD) [MIM:613735]: A syndrome characterized by corpus callosum
CC       hypoplasia or agenesis, hydrocephalus or ventricular enlargement,
CC       developmental delay, and urinary tract defects.
CC       {ECO:0000269|PubMed:24462883, ECO:0000269|PubMed:27081522}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00436}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92677.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB037860; BAA92677.1; ALT_INIT; mRNA.
DR   EMBL; AK299289; BAG61305.1; -; mRNA.
DR   EMBL; AK299579; BAG61515.1; -; mRNA.
DR   EMBL; AC092784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096534; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099792; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL096888; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445198; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445432; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06601.1; -; Genomic_DNA.
DR   EMBL; BC022264; AAH22264.1; -; mRNA.
DR   EMBL; U07809; AAA93124.1; -; mRNA.
DR   CCDS; CCDS44156.1; -. [Q12857-1]
DR   CCDS; CCDS53321.1; -. [Q12857-3]
DR   CCDS; CCDS53322.1; -. [Q12857-4]
DR   CCDS; CCDS615.1; -. [Q12857-2]
DR   RefSeq; NP_001128145.1; NM_001134673.4. [Q12857-1]
DR   RefSeq; NP_001138983.1; NM_001145511.2. [Q12857-3]
DR   RefSeq; NP_001138984.1; NM_001145512.2. [Q12857-4]
DR   RefSeq; NP_005586.1; NM_005595.5. [Q12857-2]
DR   AlphaFoldDB; Q12857; -.
DR   SMR; Q12857; -.
DR   BioGRID; 110847; 188.
DR   FunCoup; Q12857; 2138.
DR   IntAct; Q12857; 135.
DR   MINT; Q12857; -.
DR   STRING; 9606.ENSP00000360231; -.
DR   GlyCosmos; Q12857; 3 sites, 2 glycans.
DR   GlyGen; Q12857; 24 sites, 2 O-linked glycans (22 sites).
DR   iPTMnet; Q12857; -.
DR   PhosphoSitePlus; Q12857; -.
DR   BioMuta; NFIA; -.
DR   DMDM; 14194959; -.
DR   jPOST; Q12857; -.
DR   MassIVE; Q12857; -.
DR   PaxDb; 9606-ENSP00000360231; -.
DR   PeptideAtlas; Q12857; -.
DR   ProteomicsDB; 25418; -.
DR   ProteomicsDB; 30217; -.
DR   ProteomicsDB; 58986; -. [Q12857-1]
DR   ProteomicsDB; 58987; -. [Q12857-2]
DR   Pumba; Q12857; -.
DR   Antibodypedia; 1812; 288 antibodies from 31 providers.
DR   DNASU; 4774; -.
DR   Ensembl; ENST00000371187.7; ENSP00000360229.3; ENSG00000162599.18. [Q12857-2]
DR   Ensembl; ENST00000371189.8; ENSP00000360231.3; ENSG00000162599.18. [Q12857-4]
DR   Ensembl; ENST00000403491.8; ENSP00000384523.3; ENSG00000162599.18. [Q12857-1]
DR   Ensembl; ENST00000407417.7; ENSP00000384680.2; ENSG00000162599.18. [Q12857-3]
DR   GeneID; 4774; -.
DR   KEGG; hsa:4774; -.
DR   MANE-Select; ENST00000403491.8; ENSP00000384523.3; NM_001134673.4; NP_001128145.1.
DR   UCSC; uc001czv.4; human. [Q12857-1]
DR   AGR; HGNC:7784; -.
DR   CTD; 4774; -.
DR   DisGeNET; 4774; -.
DR   GeneCards; NFIA; -.
DR   GeneReviews; NFIA; -.
DR   HGNC; HGNC:7784; NFIA.
DR   HPA; ENSG00000162599; Low tissue specificity.
DR   MalaCards; NFIA; -.
DR   MIM; 600727; gene.
DR   MIM; 613735; phenotype.
DR   OpenTargets; ENSG00000162599; -.
DR   Orphanet; 401986; 1p31p32 microdeletion syndrome.
DR   VEuPathDB; HostDB:ENSG00000162599; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   GeneTree; ENSGT00950000182916; -.
DR   InParanoid; Q12857; -.
DR   OMA; XSPHATP; -.
DR   OrthoDB; 10055441at2759; -.
DR   PAN-GO; Q12857; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q12857; -.
DR   PathwayCommons; Q12857; -.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   SignaLink; Q12857; -.
DR   SIGNOR; Q12857; -.
DR   BioGRID-ORCS; 4774; 23 hits in 1192 CRISPR screens.
DR   ChiTaRS; NFIA; human.
DR   GeneWiki; NFIA; -.
DR   GenomeRNAi; 4774; -.
DR   Pharos; Q12857; Tbio.
DR   PRO; PR:Q12857; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q12857; protein.
DR   Bgee; ENSG00000162599; Expressed in medial globus pallidus and 206 other cell types or tissues.
DR   ExpressionAtlas; Q12857; baseline and differential.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; NAS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0010458; P:exit from mitosis; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0021780; P:glial cell fate specification; IEA:Ensembl.
DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0035108; P:limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0048665; P:neuron fate specification; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0060074; P:synapse maturation; IEA:Ensembl.
DR   GO; GO:0072189; P:ureter development; IEA:Ensembl.
DR   GO; GO:0019079; P:viral genome replication; NAS:UniProtKB.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492:SF6; NUCLEAR FACTOR 1 A-TYPE; 1.
DR   PANTHER; PTHR11492; NUCLEAR FACTOR I; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
DR   neXtProt; NX_Q12857; -.
DR   PharmGKB; PA31590; -.
DR   TreeFam; TF313889; -.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; DNA replication; DNA-binding; Methylation;
KW   Nucleus; Phosphoprotein; Proteomics identification; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..509
FT                   /note="Nuclear factor 1 A-type"
FT                   /id="PRO_0000100191"
FT   DNA_BIND        1..194
FT                   /note="CTF/NF-I"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00436"
FT   REGION          189..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          259..345
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          352..371
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..509
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           394..402
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000269|PubMed:31375868"
FT   COMPBIAS        189..199
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..275
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        296..309
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..341
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..457
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        469..482
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        498..509
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:24275569"
FT   MOD_RES         280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         300
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09414"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         389
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02780"
FT   MOD_RES         469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         471
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..9
FT                   /note="MYSPLCLTQ -> M (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046884"
FT   VAR_SEQ         1
FT                   /note="M -> MQMCRPASSSVLYVPTRWPGGCGATWQSCPSPPPRRTRIPQRPAVM
FT                   (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046883"
FT   VAR_SEQ         474..509
FT                   /note="TYSTPSTSPANRFVSVGPRDPSFVNIPQQTQSWYLG -> ILVPGIKVAASH
FT                   HPPDRPPDPFSTL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036620"
FT   CONFLICT        143
FT                   /note="E -> G (in Ref. 2; BAG61305)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        186
FT                   /note="A -> G (in Ref. 6; AAA93124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        240..243
FT                   /note="TGPN -> PAPT (in Ref. 6; AAA93124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        274
FT                   /note="S -> P (in Ref. 2; BAG61515)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="F -> L (in Ref. 2; BAG61305)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        358
FT                   /note="R -> G (in Ref. 2; BAG61305)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        426
FT                   /note="K -> R (in Ref. 2; BAG61305)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q12857-2:469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
SQ   SEQUENCE   509 AA;  55944 MW;  42090C6B8B229F87 CRC64;
     MYSPLCLTQD EFHPFIEALL PHVRAFAYTW FNLQARKRKY FKKHEKRMSK EEERAVKDEL
     LSEKPEVKQK WASRLLAKLR KDIRPEYRED FVLTVTGKKP PCCVLSNPDQ KGKMRRIDCL
     RQADKVWRLD LVMVILFKGI PLESTDGERL VKSPQCSNPG LCVQPHHIGV SVKELDLYLA
     YFVHAADSSQ SESPSQPSDA DIKDQPENGH LGFQDSFVTS GVFSVTELVR VSQTPIAAGT
     GPNFSLSDLE SSSYYSMSPG AMRRSLPSTS STSSTKRLKS VEDEMDSPGE EPFYTGQGRS
     PGSGSQSSGW HEVEPGMPSP TTLKKSEKSG FSSPSPSQTS SLGTAFTQHH RPVITGPRAS
     PHATPSTLHF PTSPIIQQPG PYFSHPAIRY HPQETLKEFV QLVCPDAGQQ AGQVGFLNPN
     GSSQGKVHNP FLPTPMLPPP PPPPMARPVP LPVPDTKPPT TSTEGGAASP TSPTYSTPST
     SPANRFVSVG PRDPSFVNIP QQTQSWYLG
//
